Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

Testosterone may slow down wound healing and increase inflammation.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Puerariae Flos extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Ganoderma lucidum may help treat enlarged prostate in rats.

Transcutol P best increases Finasteride absorption for hair loss treatment.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Finasteride exposure harms tadpole reproduction and hormone balance.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Finasteride and analogues separated using LC-MS-MS technique.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Post-finasteride syndrome's existence is uncertain; more research needed.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.